Diamond Biofund Statistics

Total Valuation

Diamond Biofund has a market cap or net worth of TWD 19.63 billion. The enterprise value is 14.62 billion.

Market Cap	19.63B
Enterprise Value	14.62B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Diamond Biofund has 851.80 million shares outstanding. The number of shares has increased by 9.19% in one year.

Current Share Class	n/a
Shares Outstanding	851.80M
Shares Change (YoY)	+9.19%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	25.24%
Owned by Institutions (%)	5.17%
Float	179.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	-8.81
PB Ratio	1.89
P/TBV Ratio	1.89
P/FCF Ratio	17.45
P/OCF Ratio	17.24
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.81
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	13.00

Financial Position

The company has a current ratio of 24.76, with a Debt / Equity ratio of 0.01.

Current Ratio	24.76
Quick Ratio	24.75
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	0.10
Interest Coverage	-636.63

Financial Efficiency

Return on equity (ROE) is -21.67% and return on invested capital (ROIC) is -12.77%.

Return on Equity (ROE)	-21.67%
Return on Assets (ROA)	-12.65%
Return on Invested Capital (ROIC)	-12.77%
Return on Capital Employed (ROCE)	-22.92%
Revenue Per Employee	-67.54M
Profits Per Employee	-76.30M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.42% in the last 52 weeks. The beta is 1.51, so Diamond Biofund's price volatility has been higher than the market average.

Beta (5Y)	1.51
52-Week Price Change	-41.42%
50-Day Moving Average	26.11
200-Day Moving Average	34.07
Relative Strength Index (RSI)	46.32
Average Volume (20 Days)	483,895

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diamond Biofund had revenue of TWD -2.23 billion and -2.52 billion in losses. Loss per share was -2.96.

Revenue	-2.23B
Gross Profit	-2.23B
Operating Income	-2.40B
Pretax Income	-2.40B
Net Income	-2.52B
EBITDA	-2.39B
EBIT	-2.40B
Loss Per Share	-2.96

Full Income Statement

Balance Sheet

The company has 5.13 billion in cash and 117.83 million in debt, giving a net cash position of 5.01 billion or 5.88 per share.

Cash & Cash Equivalents	5.13B
Total Debt	117.83M
Net Cash	5.01B
Net Cash Per Share	5.88
Equity (Book Value)	10.37B
Book Value Per Share	12.18
Working Capital	4.93B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.14 billion and capital expenditures -14.24 million, giving a free cash flow of 1.12 billion.

Operating Cash Flow	1.14B
Capital Expenditures	-14.24M
Free Cash Flow	1.12B
FCF Per Share	1.32

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	107.66%
Pretax Margin	107.52%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Diamond Biofund does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.19%
Shareholder Yield	-9.19%
Earnings Yield	-12.82%
FCF Yield	5.73%

Dividend Details

Stock Splits

The last stock split was on August 7, 2023. It was a forward split with a ratio of 1.18.

Last Split Date	Aug 7, 2023
Split Type	Forward
Split Ratio	1.18

Scores

Diamond Biofund has an Altman Z-Score of 67.32.

Altman Z-Score	67.32
Piotroski F-Score	n/a